Brexit and Healthcare Industry – Implications for Pharma – The Story So Far
It may take up to five years for the healthcare industry to stabilize in the event of a ‘no deal’ Brexit. This is the consensus opinion among professionals surveyed in the pharmaceutical industry, according to GlobalData, a leading data and analytics company.
GlobalData’s latest report, ‘Brexit and the Healthcare Industry – Implications for Pharma – The Story So Far’, revealed that 66% of participants across the US, UK, and EU suggested that it would take more than three years for the UK to stabilize its healthcare industry, compared to only 9% of respondents who indicated that stabilization would occur in less than 12 months.
GlobalData’s Brexit and the Healthcare Industry – Implications for Pharma – the Story so far provides in-house analyst expertise on the results of a 10 minutes survey of 149 GlobalData Pharma clients and prospects which was fielded from February 4, 2019 to February 24, 2019. Participants answered questions about how they expected Brexit to affect the healthcare sector, both within and outside of the UK.
Components of the slide deck include:
• Outcomes of Brexit – best and most likely outcomes of Brexit providing respondent mix by geography
• Factors to Impact Healthcare—key factors to impact the post-Brexit UK healthcare industry providing respondent mix by region and seniority level as compared to Q1, Q2, and Q3
• Impact on Research and Manufacturing — key factors to impact healthcare research and manufacturing in the UK post-Brexit providing respondent mix by region and seniority level as compared to Q1, Q2, and Q3
• Impact on Corporate Strategy —level of impact of Brexit on corporate strategy providing respondent mix by region, seniority level, and headquarter location as compared to Q1, Q2, and Q3
• Impact on Relocation — impact of Brexit on staff and headquarter relocation as indicated by resondents whose headquarters is located in the UK as compared to Q1, Q2, and Q3
Reasons to Buy
Develop and design your corporate strategies post-Brexit through an in-house expert analysis of the key factors to impact the post-Brexit UK healthcare industry.
Develop business strategies by understanding the key factors to impact healthcare research and manufacturing in the UK post-Brexit.
Stay up to date on the industry’s changing sentiment towards Brexit from within the healthcare industry with quarterly surveys.
Identify emerging industry trends post-Brexit to gain a competitive advantage.
Table of Contents
1 Table of Contents (PowerPoint Deck)
1 Study Design
1.2 Background, Objectives, and Design
1.3 Respondent Mix – Geography
1.4 Respondent Mix – Seniority Level
1.5 Respondent Mix – Headquarters Location
2 Executive Summary
2.1 Key Findings
2.2 Change in Brexit Sentiment since Q3
3 Overview of UK Pharma Industry
3.1 The UK Pharma Industry – A Key Driver of the UK Economy
3.2 The UK as an Attractive Location for Clinical Trials
3.3 Brexit Timeline
4 Outcomes of Brexit
4.1 Best and Most Likely Outcomes of Brexit – No Brexit Is the Best Outcome but Not the Most Likely
4.2 Best and Most Likely Outcomes of Brexit – A Closer Look at Geography
4.3 At Least Three Years Necessary to Stabilize the UK Healthcare Industry in a “No Deal” Brexit
5 Factors to Impact Healthcare
5.1 Key Factors to Impact the UK Healthcare Industry After Brexit
5.2 Key Factors to Impact the UK Healthcare Industry After Brexit – A Closer Look at the Top Four Factors
6 Impact on Research and Manufacturing
6.1 Will Healthcare Research and Manufacturing Be Impacted Following Brexit? – Respondent Mix by Location
6.2 Will Healthcare Research and Manufacturing Be Impacted Following Brexit? – Respondent Mix by Seniority Level
6.3 Why the UK WILL Be an Attractive Destination for Healthcare Companies
6.4 Why the UK WILL NOT Be an Attractive Destination for Healthcare Companies
6.5 Is the UK as an Attractive Destination for Healthcare Research and Manufacturing? – In Their Words
7 Impact on Corporate Strategy
7.1 The Impact of Brexit on Corporate Strategy
7.2 The Impact of Brexit on Corporate Strategy, by Location – A Closer Look at the Numbers
7.3 The Impact of Brexit on Corporate Strategy, by Seniority Level
7.4 How Has Brexit Most Influenced Corporate Strategy? – Investing Resources into Managing the Potential Impact of Brexit Is a Major Concern
7.5 How Has Brexit Most Influenced Corporate Strategy? – In Their Words
8 Impact on Relocation
8.1 Potential of Relocation of Staff Due to Brexit – All Respondents
8.2 Potential of Relocation of Staff Due to Brexit – A Closer Look at Geography and Seniority Level
8.3 Relocation of Headquarters Unlikely After Brexit
9 Summary of Key Findings
10.1 Related and Upcoming Reports
10.4 About the Authors
10.5 About Thematic Research
10.6 About Thematic Reports
10.7 About GlobalData
10.8 Contact Us
Get in touch to find out about our multi-purchase discounts
Tel +44 (0) 20 7947 2960
Every customer’s requirement is unique. We understand that and can customize the report basis your exact research requirements pertaining to market insights, innovation insights, strategy and planning, and competitive intelligence. You can also avail the option of purchasing stand-alone sections of the report or request for a country specific report.
Still undecided about purchasing this report?
“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.
GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”
“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”
Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.
Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.